ZA922755B - Abrogation of viral resistance to nucleoside analogues by double-stranded rnas - Google Patents
Abrogation of viral resistance to nucleoside analogues by double-stranded rnasInfo
- Publication number
- ZA922755B ZA922755B ZA922755A ZA922755A ZA922755B ZA 922755 B ZA922755 B ZA 922755B ZA 922755 A ZA922755 A ZA 922755A ZA 922755 A ZA922755 A ZA 922755A ZA 922755 B ZA922755 B ZA 922755B
- Authority
- ZA
- South Africa
- Prior art keywords
- abrogation
- double
- nucleoside analogues
- stranded rnas
- viral resistance
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68620091A | 1991-04-16 | 1991-04-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA922755B true ZA922755B (en) | 1993-04-28 |
Family
ID=24755338
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA922755A ZA922755B (en) | 1991-04-16 | 1992-03-20 | Abrogation of viral resistance to nucleoside analogues by double-stranded rnas |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0581906A4 (en) |
| JP (1) | JPH06507624A (en) |
| CN (1) | CN1082819C (en) |
| AU (1) | AU671800B2 (en) |
| CA (1) | CA2102221A1 (en) |
| IE (1) | IE920873A1 (en) |
| MX (1) | MX9201711A (en) |
| PT (1) | PT100340A (en) |
| WO (1) | WO1992018004A1 (en) |
| ZA (1) | ZA922755B (en) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4945082A (en) * | 1985-08-26 | 1990-07-31 | Hem Research, Inc. | Controlled dsRNA therapy for human viral infections |
| US4795744A (en) * | 1986-07-17 | 1989-01-03 | Hem Research, Inc. | Modulation of AIDS virus-related events by double-stranded RNAS |
| US4820696A (en) * | 1985-08-26 | 1989-04-11 | Hem Research, Inc. | Modulation of aids virus-related events by double-stranded RNAS |
| US4950652A (en) * | 1987-03-23 | 1990-08-21 | Hem Research, Inc. | dsRNAs for combination therapy in the treatment of viral diseases |
-
1992
- 1992-03-12 CA CA002102221A patent/CA2102221A1/en not_active Abandoned
- 1992-03-12 JP JP4510192A patent/JPH06507624A/en active Pending
- 1992-03-12 WO PCT/US1992/001972 patent/WO1992018004A1/en not_active Application Discontinuation
- 1992-03-12 AU AU18718/92A patent/AU671800B2/en not_active Ceased
- 1992-03-12 EP EP92917298A patent/EP0581906A4/en not_active Withdrawn
- 1992-03-19 IE IE087392A patent/IE920873A1/en unknown
- 1992-03-20 ZA ZA922755A patent/ZA922755B/en unknown
- 1992-04-03 PT PT100340A patent/PT100340A/en not_active Application Discontinuation
- 1992-04-06 CN CN92102227A patent/CN1082819C/en not_active Expired - Fee Related
- 1992-04-13 MX MX9201711A patent/MX9201711A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0581906A1 (en) | 1994-02-09 |
| JPH06507624A (en) | 1994-09-01 |
| AU671800B2 (en) | 1996-09-12 |
| IE920873A1 (en) | 1992-10-21 |
| AU1871892A (en) | 1992-11-17 |
| MX9201711A (en) | 1992-10-01 |
| PT100340A (en) | 1993-07-30 |
| EP0581906A4 (en) | 1997-07-23 |
| CN1082819C (en) | 2002-04-17 |
| CA2102221A1 (en) | 1992-10-17 |
| CN1068035A (en) | 1993-01-20 |
| WO1992018004A1 (en) | 1992-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| OA09679A (en) | Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents | |
| EP0570514A4 (en) | Methylene phosphonate nucleoside analogs and oligonucleotide analogs made therefrom | |
| IL90752A0 (en) | Purine nucleoside analogues,their preparation and pharmaceutical compositions containing them | |
| CA2068943A1 (en) | 1,3-oxathiolanes useful in the treatment of hepatitis | |
| NZ223868A (en) | Synergistic treatment of viral infections by dsrna combined with viral inhibitors | |
| CS385191A3 (en) | Antiviral nucleosides | |
| GB9116601D0 (en) | 1,3-oxathiolane nucleoside analogues | |
| DE19575021I2 (en) | Therapeutic nucleosides | |
| NZ227663A (en) | Purine nucleoside analogues, pyrimidine derivatives and pharmaceutical compositions | |
| EP0113078A3 (en) | Dna complementary to rna of human leukemia virus | |
| ZA939677B (en) | Use of dideoxy nucleoside analogues in the treatment of viral infections | |
| EP1499712A4 (en) | Hepatitis b viral variants with reduced susceptibility to nucleoside analogs and uses thereof | |
| HUP0200294A3 (en) | Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs | |
| LV10100A (en) | Purine nucleoside phosphorylase inhibitors and their uptake | |
| NO932287D0 (en) | 2'-DEOXY-2 ', 2'-DIFLUOR (2,6,8-SUBSTITUTED) PURINE NUCLEOSIDES WITH ANTIVIRAL AND ANTICANCER ACTIVITY, AND INTERMEDIATES | |
| ZA922755B (en) | Abrogation of viral resistance to nucleoside analogues by double-stranded rnas | |
| PT1140937E (en) | ANALOGS OF ANTIVIRAL NUCLEOSIDES | |
| AU3089892A (en) | Antiviral agent comprising antisense oligonucleotides complementary to the bhrf1 gene of epstein-barr virus | |
| DE3363728D1 (en) | Determination of the sensitivity of virus to antiviral agents | |
| OA09555A (en) | Inhibition of HIV using synergistic combinations of nucleoside derivatives | |
| CY2006A (en) | Antiviral combinations containing nucleoside analogs | |
| GB9111967D0 (en) | 2,5'-nucleotide analogs as antiviral agents | |
| ZA866418B (en) | Modulation of aids virus-related events by double-stranded rnas | |
| IL92367A0 (en) | Antiviral compositions containing nucleoside derivatives | |
| ZA916542B (en) | New phospholipid derivatives of nucleosides,processes for their preparation and antiviral use |